Case Study
Monday, October 07
11:30 AM - 12:00 PM
Live in Berlin
Less Details
Presentation of most recent development in CEE health care system incl. novel HTA approaches, patient inclusion in decision making and overall rare disease patient access landscape:
With so many changes in healthcare policies not only on the EU, but on national levels, access professionals need to leverage those change and adapt as quickly as possible. Transformation of the Czech healthcare system (MCDA HTA pathway), separate medical fund & HTA pathway for OMP’s in PL, patient inclusion in HTA in CZ and PL, are only few examples of the change that affect or will affect some CEE countries in the next years.
In this presentation you will learn about:
Market Access and Health Economics expert with more than 16 years successful track record in implementing strategy to achieve fast and broad access to treatment to patients. Experience gained across major pharmaceutical companies in a broad range of therapeutic areas in France and in CEE countries including Russia and Israel. Organised, passionate, creative, engaging and focused on people and results.